Device Medical Device

(Bi2) Igt Systems Undivided

Payments companies reported to CMS as associated with (Bi2) Igt Systems Undivided. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$52Kassociated payments (2023-2025)

35clinicians with associated payments

1company reporting

By year

2024 $52K

Payments reported as associated with (Bi2) Igt Systems Undivided, per program year, as reported to CMS.

Who makes it

Philips North America LLC $52K associated with (Bi2) Igt Systems Undivided (2023-2025)

Specialties most often involved

Vascular & Interventional Radiology $28K

Body Imaging $10K

Neurological Surgery $5,825

Neuroradiology $5,433

Diagnostic Radiology $1,147

Pulmonary Disease $889

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with (Bi2) Igt Systems Undivided

These are the largest totals companies reported as associated with (Bi2) Igt Systems Undivided. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Jinsoo Keyoung	Stanford, CA	Body Imaging	$10,352.65
Christopher Baker	Newport Beach, CA	Vascular & Interventional Radiology	$10,352.35
Alexander Misono	Newport Beach, CA	Vascular & Interventional Radiology	$6,026.30
Kanti Kolli	San Francisco, CA	Vascular & Interventional Radiology	$5,629.44
Luis Savastano	San Francisco, CA	Neurological Surgery	$5,465.95
Ryan Lokken	San Francisco, CA	Vascular & Interventional Radiology	$5,433.40
Steven Hetts	San Francisco, CA	Neuroradiology	$5,433.40
Christopher Hedley	Pasadena, CA	Diagnostic Radiology	$613.62
Demi Dawkins	Memphis, TN	Neurological Surgery	$358.98
Brian Coley	Cincinnati, OH	Diagnostic Radiology	$284.52

Prescribed (Bi2) Igt Systems Undivided?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.